Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 1999, p. 5352-5362, Vol. 19, No. 8
Howard Hughes Medical
Institute3 and Department of Cell
Biology,1 Vanderbilt University School of
Medicine, Nashville, Tennessee 37232, and Department of
Microbiology, New York University School of Medicine, New York, New
York 100162
Received 1 April 1999/Accepted 10 May 1999
Myb-related cdc5p is required for G2/M progression in
the yeast Schizosaccharomyces pombe. We report here that
all detectable cdc5p is stably associated with a multiprotein 40S
complex. Immunoaffinity purification has allowed the identification of
10 cwf (complexed with cdc5p) proteins. Two (cwf6p and cwf10p) are
members of the U5 snRNP; one (cwf9p) is a core snRNP protein. cwf8p is
the apparent ortholog of the Saccharomyces cerevisiae
splicing factor Prp19p. cwf1+ is allelic to the
prp5+ gene defined by the S. pombe
splicing mutant, prp5-1, and there is a strong negative
genetic interaction between cdc5-120 and prp5-1. Five cwfs have not been recognized previously as
important for either pre-mRNA splicing or cell cycle control. Further
characterization of cwf1p, cwf2p, cwf3p, and cwf4p demonstrates that
they are encoded by essential genes, cosediment with cdc5p at 40S, and
coimmunoprecipitate with cdc5p. We further show that cdc5p associates
with the U2, U5, and U6 snRNAs and that cells lacking
cdc5+ function are defective in pre-mRNA
splicing. These data raise the possibility that the cdc5p complex is an
intermediate in the assembly or disassembly of an active S. pombe spliceosome.
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Myb-Related Fission Yeast cdc5p Is a Component of a
40S snRNP-Containing Complex and Is Essential for Pre-mRNA
Splicing

and
*
Corresponding author. Mailing address: Department of
Cell Biology, Vanderbilt University School of Medicine, Nashville, TN 37232. Phone: (615) 343-9500. Fax: (615) 343-0723.
Present address: Memorial Sloan-Kettering Cancer Center, New York,
NY 10021.
Present address: Regeneron Pharmaceuticals, Inc., Tarrytown,
NY 10591-6707.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|